User contributions

Jump to: navigation, search
Search for contributionsExpandCollapse
⧼-contribs-top⧽
⧼-contribs-date⧽

  • 23:34, 21 November 2024 diff hist +6,707 N Dahlgaarddall2509Created page with "n-based neoadjuvant anti-HER2 therapy may be applied as an optimal treatment duration for screening high-risk HER2-positive breast cancer patients for escalation treatment. Fu..." current